{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/tuberculosis/background-information/risk-factors/","result":{"pageContext":{"chapter":{"id":"f2d695cb-4d0e-5513-a7f3-01df45726347","slug":"risk-factors","fullItemName":"Risk factors","depth":2,"htmlHeader":"<!-- begin field b1a0ded4-e10a-42db-acf4-ea2d6448d91e --><h2>What are the risk factors?</h2><!-- end field b1a0ded4-e10a-42db-acf4-ea2d6448d91e -->","summary":"","htmlStringContent":"<!-- begin item 76420868-7f17-43de-bf78-778d8fe293bd --><!-- begin field 23875961-3f9f-46e0-8043-06e86974128e --><ul><li><strong>Risk factors for tuberculosis (TB) infection include:</strong><ul><li>Being born in high prevalence areas (defined as more than 40 cases per 100,000 population per year).<ul><li>People born outside the UK have a TB incidence rate 13 times higher than people born in the UK [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>].</li><li>In 2017, the most common countries of origin of non-UK born TB cases were India, Pakistan, Romania, Bangladesh, and Somalia. There is a continued elevated risk of TB in the settled migrant population of the UK. The Public Health England (PHE) document <a href=\"http://www.gov.uk/government/publications/tuberculosis-tb-by-country-rates-per-100000-people\" data-hyperlink-id=\"8092594c-9452-4724-a2d6-aa1000a2303b\">Tuberculosis rates by country</a> has detailed information on worldwide tuberculosis rates.</li></ul></li><li>Children less than 5 years of age.<ul><li>Young children are at increased risk of developing more severe active disease, and in particular extrapulmonary TB.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/tuberculosis/diagnosis/screening/\">Close contacts</a>.<ul><li>Close contact with a person with active pulmonary or laryngeal TB, for example, a person living in the same household, or colleagues working in close proximity.</li></ul></li><li>History of untreated or inadequately treated active TB infection.<ul><li>In 2017, 5.9% of people with TB had a previous diagnosis more than 12 months before their current notification [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>].</li></ul></li><li>Co-morbid conditions.<ul><li>These include HIV, diabetes mellitus, end-stage chronic kidney disease receiving renal replacement therapy, previous gastrectomy or jejunoileal bypass surgery, occupational lung disease (for example silicosis), haematological malignancy, history of solid organ transplantation, and malnutrition.</li></ul></li><li>Immunosuppressive drugs.<ul><li>People taking prolonged duration of high-dose corticosteroids, chemotherapy, or anti-tumour necrosis factor (TNF)-alpha biologic treatment for inflammatory conditions, such as infliximab, are at increased risk of reactivation of latent TB.</li></ul></li><li>Under-served groups.<ul><li>The most deprived 10% of the UK population have a TB rate more than 7 times higher than the least deprived 10% of the population [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>].</li><li>People using homeless hostels, shelters, and day centres, and people living in prison or detention centres, are particularly at risk.</li><li>The incidence of multidrug-resistant or rifampicin-resistant TB was almost two times higher in people with a social risk factor (2.7%) compared with those without (1.5%). In addition, outcomes in people with drug-susceptible TB who had a social risk factor were worse (6.3% died and 6.5% were lost to follow-up) compared with those without [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>].</li></ul></li><li>History of excessive alcohol, injecting drug users, and smokers.<ul><li>These are risk factors for developing active TB.</li></ul></li></ul></li><li><strong>Be aware that TB infection may also occur in people without any risk factors.</strong></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">British Thoracic Society, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Hartman-Adams, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Whittaker, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Dheda, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">NICE, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Bracchi, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Migliori, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>]</p><!-- end field 23875961-3f9f-46e0-8043-06e86974128e --><!-- end item 76420868-7f17-43de-bf78-778d8fe293bd -->","topic":{"id":"c8d06469-2b39-5daa-bda8-b076b7204860","topicId":"c1897d19-8ea9-40e5-84a7-c45a80747a3e","topicName":"Tuberculosis","slug":"tuberculosis","lastRevised":"Last revised in January 2019","chapters":[{"id":"7216c242-e6e9-5726-9bad-d4bbd4071072","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"aa25f749-53e8-5ff7-a3be-ddfd9f824295","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9c40ce5c-b940-5a6e-a414-cb379ae5f2c1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5b948ae0-2789-5df7-b344-42eb6ae4054d","slug":"changes","fullItemName":"Changes"},{"id":"706989f4-45e1-583c-bcbc-d08833e25634","slug":"update","fullItemName":"Update"}]},{"id":"5edbfe3e-e825-5d79-a1d2-fa1b3b258467","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2e115c8b-8ca5-587b-bf34-83ddeeae2383","slug":"goals","fullItemName":"Goals"},{"id":"dbbfc2a1-e777-55e9-b654-44db5bf1efb4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bdce292e-6c5f-53df-a014-fc8432efa249","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1f5efb77-1619-5cf3-be88-86fd03247324","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f93c9e3-2eb5-5d68-bbc0-99b7ea53b835","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a028a0db-e900-5a0f-88ba-f333bcd824c9","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"24cda0d7-3e0d-58d5-9229-0a15e99013c4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c26e051a-e3f8-57b8-95af-985e9e93a3aa","slug":"definition","fullItemName":"Definition"},{"id":"2deaf55e-4677-569a-a2e0-a8748b44829f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f2d695cb-4d0e-5513-a7f3-01df45726347","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"dc328fb0-65a2-5d6a-94fe-0bfa42962928","slug":"complications","fullItemName":"Complications"},{"id":"72382f51-4bac-5de9-9caf-c6f16082070d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"7e56c88f-1492-52ab-9f0b-cfc6b986db85","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b5294e44-2490-5ba7-8d81-0085ae3114a7","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"b90838b4-5d6d-57e8-aabd-afaad5a60e3f","slug":"investigations","fullItemName":"Investigations"},{"id":"8d7ee3e2-c863-574f-a042-172b8d909e84","slug":"screening","fullItemName":"Screening"},{"id":"a6c65c83-026b-50f1-b32d-5d28e8e7ae46","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"880c8c31-e325-5d4b-b4de-6ac05a1a9f94","fullItemName":"Management","slug":"management","subChapters":[{"id":"2ab22745-718a-5096-a75f-2e6c874d6267","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"fd726cd9-2566-5903-9e38-d7333b140c5a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"3ac0b667-89b4-5934-98e1-938fd35e537f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a3834823-1bb2-52a0-92c5-cb04316db808","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b2e2271f-aaf8-57a5-aba4-42de8a475bc5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e611555b-70b5-5ea6-8e53-5220621e1603","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fdb64832-ab19-58f6-978e-d73fe8657b7d","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"200b04d2-7d10-5430-abe3-3802b135aea7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74113d46-a800-5f0b-9d3d-096dc4137936","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"24cda0d7-3e0d-58d5-9229-0a15e99013c4","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}